Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8846661 Diazahomoadamantane derivatives and methods of use thereof

Patent 8846661 was granted and assigned to AbbVie Inc. on September, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 2 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12103926 Compounds for treating huntington's disease
0
Edits on 4 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11858941 Heterocyclic and heteroaryl compounds for treating Huntington's disease
0
Edits on 11 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11780839 Compounds for treating Huntington's disease
Edits on 14 Jul, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 14 Jul, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08846661 Diazahomoadamantane derivatives and methods of use thereof US Patent 8846661 Diazahomoadamantane derivatives and methods of use thereof

Infobox
Patent Number
0884666100
Patent Number
884666100
Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0884666100
Edits on 2 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
AbbVie Inc.
AbbVie Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
088466610
Date of Patent
September 30, 2014
0
Patent Application Number
128187640
Date Filed
June 18, 2010
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=088466610
Patent Primary Examiner
‌
Andrew D. Kosar
0
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
AbbVie Inc.
AbbVie Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
088466610
Date of Patent
September 30, 2014
0
Patent Application Number
128187640
Date Filed
June 18, 2010
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=088466610
Patent Primary Examiner
‌
Andrew D. Kosar
0
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=08846661
Edits on 27 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 27 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 08846661 Diazahomoadamantane derivatives and methods of use thereof

Infobox
Is a
Patent
Patent
Current assignee
AbbVie Inc.
AbbVie Inc.
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08846661
Date of patent
September 30, 2014
Patent application number
12818764
Date Filed
June 18, 2010
Patent primary examiner
‌
Andrew D. Kosar

Find more entities like US Patent 8846661 Diazahomoadamantane derivatives and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.